The Department of Health and Family Welfare vide notification dated the 13th January, 2022 has issued the New Drugs and Clinical Trials (Amendment) Rules, 2022. The amendment has extended the scope of new drugs to include cell or stem cell derived product. Previously the definition of new drug under the New Drugs and Clinical Trials Rules only included stem cell derived product.
It has been decided that the said Circular shall now come into force with effect from April 01, 2025. The Regulated Entities are therefore directed
The rise in phishing attempts impersonating IFSCA employees serves as a timely reminder of the importance of cybersecurity vigilance. Whether you are an individual, a
This initiative aims to streamline co-investment and leverage transactions within International Financial Services Centres (IFSCs). By operationalizing the SPV model, the IFSCA seeks to bolster
The grounds of arrest informed in writing must convey to the arrested accused all basic facts on which he was being arrested so as to
Stay up-to-date with the latest regulatory developments from Legality Alerts, directly in your inbox. Never miss another important regulatory compliance news alert.
Solutions
Resources
